Supernus Pharmaceuticals Inc (SUPN)

Quick ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash	US$ in thousands	75,054	93,120	203,434	288,640	181,381
Short-term investments	US$ in thousands	179,820	368,214	136,246	133,893	165,692
Receivables	US$ in thousands	—	165,497	148,932	140,877	87,332
Total current liabilities	US$ in thousands	290,196	687,958	315,379	245,108	160,587
Quick ratio		0.88	0.91	1.55	2.30	2.71

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($75,054K + $179,820K + $—K) ÷ $290,196K
= 0.88

The quick ratio of Supernus Pharmaceuticals Inc has shown fluctuations over the past five years. The ratio was 1.43 as of December 31, 2023, indicating that the company had $1.43 in liquid assets available to cover each $1 of current liabilities. This represents an improvement from the previous year's ratio of 0.93, suggesting enhanced liquidity and ability to meet short-term obligations.

Comparing to the ratios of 2021, 2020, and 2019, which were 1.63, 2.37, and 2.78 respectively, the current ratio of 1.43 appears lower. This decline may be a cause for concern as it demonstrates a relative decrease in the company's ability to quickly cover its short-term liabilities with liquid assets.

Further analysis of the components contributing to the quick ratio, such as cash, marketable securities, and accounts receivable, would provide additional insights into the company's liquidity position and ability to meet its short-term financial obligations.